A groundbreaking shift in our drug policy has occurred, as the regulators allow the use of psilocybin mushrooms for therapeutic treatment. Previously, these substances were severely restricted, but a growing body of research suggests they could offer benefits for emotional illnesses like anxiety. This development represents a substantial step towar